Denali Advisors LLC Kura Oncology, Inc. Transaction History

Denali Advisors LLC

  • $916 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 21, 2023
BUY
$10.71 - $14.6 $55,692 - $75,920
5,200 Added 136.84%
9,000 $110,000
Q4 2022

Feb 09, 2023
SELL
$11.23 - $16.9 $30,321 - $45,629
-2,700 Reduced 41.54%
3,800 $47,000
Q2 2022

Jul 18, 2022
BUY
$10.71 - $18.33 $28,917 - $49,490
2,700 Added 71.05%
6,500 $119,000
Q4 2021

Jan 21, 2022
BUY
$12.22 - $19.57 $46,436 - $74,366
3,800 New
3,800 $53,000

Others Institutions Holding KURA

# of Institutions
187
Shares Held
81.8M
Call Options Held
42.1K
Put Options Held
34K
View Full List

About Kura Oncology, Inc.

KURA Quotes by TradingView
  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $526M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Denali Advisors LLC Portfolio

Follow Denali Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Denali Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Denali Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email